Results 181 to 190 of about 28,157 (212)

<i>CMTM8</i> variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/polymorphonuclear myeloid-derived suppressor cell activity. [PDF]

Front Immunol
Testori A, Mulas A, Marongiu M, Orrù V, Lobina M, Piras MG, Lutzu E, Curreli N, Politi C, Mobrici M, Iervasi G, Corda D, De Felice M, Testa A, Devoto M, Steri M, Fiorillo E, SerGenCovid-19 Investigators.   +17 more
europepmc   +1 more source

Vaccine Platform-Dependent Differential Impact on Microbiome Diversity: Potential Advantages of Protein Subunit Vaccines. [PDF]

Vaccines (Basel)
Seong H, Yoon JG, Nham E, Choi YJ, Noh JY, Cheong HJ, Kim WJ, Lim S, Song JY.   +8 more
europepmc   +1 more source

Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study. [PDF]

PLoS Med
Kawamoto A, Hashida M, Ishida K, Furihata K, Ota A, Takahashi K, Sakakibara S, Nakano T, Takeshita F.   +8 more
europepmc   +1 more source

Primary and Booster COVID-19 Vaccination in Patients with Sjögren's Disease: Data from the Longitudinal SAFER Cohort Study. [PDF]

Vaccines (Basel)
Barbosa Beloni Lirio M, Machado KLLL, Assis Martins-Filho O, Miyamoto ST, Gurtler Pinheiro de Oliveira Y, Vieira Serrano É, Geraldo Mill J, Rosemarie Lallemand Tapia K, Baptista Ferreira L, Ribeiro de Oliveira J, Gouvea MDPG, Rodrigues Aguiar LG, Souza BO, Cruz VA, Xavier RM, Teixeira Carvalho A, de Souza VA, Ferreira GA, Monticielo OA, Neto ETDR, Sato EI, Pileggi GS, Valim V.   +22 more
europepmc   +1 more source

Quantity of Work Days Lost Due To Side Effects Among Health Care Workers Vaccinated with Bnt162b2 and Chadox1

Christian Scheer, Sven‐Olaf Kuhn, Marén Fricke, Lars Lars G. Eckerle, Astrid Radau, Lars Kaderali, Matthias Gründling, Marcus Vollmer   +7 more
openalex   +1 more source

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort. [PDF]

iScience
Oluka GK, Katende JS, Kato L, Ankunda V, Sembera J, Ejou P, Odoch G, Namuyanja A, Kaleebu P, Serwanga J.   +9 more
europepmc   +1 more source

A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. [PDF]

Vaccines (Basel)
Bourdon PS, Duriseti R, Gromoll HC, Dalton DK, Bardosh K, Krug AE.   +5 more
europepmc   +1 more source

Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant Neutralization. [PDF]

J Med Virol
Torres C, Jiménez A, Deulofeu M, Prenafeta A, Dobaño C, Moncunill G, Ferrer L, Molinos-Albert LM.   +7 more
europepmc   +1 more source

First Paediatric Case of mRNA COVID-19 Vaccine Associated New Onset Systemic Myasthenic Crisis. [PDF]

Sisli Etfal Hastan Tip Bul
Kirik S, Agar M, Akyol HG, Kirik Y.
europepmc   +1 more source

Autoantibody production in pregnancy: relationship with mRNA BNT162b2 immunization, active COVID-19, and pre-eclampsia. [PDF]

Front Immunol
da Silva MC, Diniz GTN, Correia MJDS, da Silva NCH, Barbosa CRM, Ferreira ALCG, de Melo MIB, de Magalhães JJF, Donadi EA, Souza AI, Lucena-Silva N.   +10 more
europepmc   +1 more source